ID   TEX14_HUMAN             Reviewed;        1497 AA.
AC   Q8IWB6; A6NH19; Q7RTP3; Q8ND97; Q9BXT9;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2006, sequence version 2.
DT   22-APR-2020, entry version 156.
DE   RecName: Full=Inactive serine/threonine-protein kinase TEX14;
DE   AltName: Full=Protein kinase-like protein SgK307;
DE   AltName: Full=Sugen kinase 307;
DE   AltName: Full=Testis-expressed sequence 14;
DE   AltName: Full=Testis-expressed sequence 14 protein;
GN   Name=TEX14; Synonyms=SGK307;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Kohrer K., Ottenwalder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 480-1497 (ISOFORM 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=11279525; DOI=10.1038/86927;
RA   Wang P.J., McCarrey J.R., Yang F., Page D.C.;
RT   "An abundance of X-linked genes expressed in spermatogonia.";
RL   Nat. Genet. 27:422-426(2001).
RN   [5]
RP   IDENTIFICATION, AND ALTERNATIVE SPLICING (ISOFORM 2).
RX   PubMed=12711554; DOI=10.1016/S1567-133X(03)00036-X;
RA   Wu M.H., Rajkovic A., Burns K.H., Yan W., Lin Y.N., Matzuk M.M.;
RT   "Sequence and expression of testis-expressed gene 14 (Tex14): a gene
RT   encoding a protein kinase preferentially expressed during
RT   spermatogenesis.";
RL   Gene Expr. Patterns 3:231-236(2003).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CEP55.
RX   PubMed=20176808; DOI=10.1128/MCB.01392-09;
RA   Iwamori T., Iwamori N., Ma L., Edson M.A., Greenbaum M.P., Matzuk M.M.;
RT   "TEX14 interacts with CEP55 to block cell abscission.";
RL   Mol. Cell. Biol. 30:2280-2292(2010).
RN   [7]
RP   PHOSPHORYLATION, AND MUTAGENESIS OF 614-SER--THR-618 AND 726-SER--THR-728.
RX   PubMed=22405274; DOI=10.1016/j.molcel.2012.01.013;
RA   Mondal G., Ohashi A., Yang L., Rowley M., Couch F.J.;
RT   "Tex14, a plk1-regulated protein, is required for kinetochore-microtubule
RT   attachment and regulation of the spindle assembly checkpoint.";
RL   Mol. Cell 45:680-695(2012).
RN   [8]
RP   INVOLVEMENT IN SPGF23, AND TISSUE SPECIFICITY.
RX   PubMed=28206990; DOI=10.1038/gim.2016.225;
RA   Gershoni M., Hauser R., Yogev L., Lehavi O., Azem F., Yavetz H.,
RA   Pietrokovski S., Kleiman S.E.;
RT   "A familial study of azoospermic men identifies three novel causative
RT   mutations in three new human azoospermia genes.";
RL   Genet. Med. 19:998-1006(2017).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-88; GLU-321; CYS-443 AND MET-559.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Required both for the formation of intercellular bridges
CC       during meiosis and for kinetochore-microtubule attachment during
CC       mitosis. Intercellular bridges are evolutionarily conserved structures
CC       that connect differentiating germ cells and are required for
CC       spermatogenesis and male fertility. Acts by promoting the conversion of
CC       midbodies into intercellular bridges via its interaction with CEP55:
CC       interaction with CEP55 inhibits the interaction between CEP55 and
CC       PDCD6IP/ALIX and TSG101, blocking cell abscission and leading to
CC       transform midbodies into intercellular bridges. Also plays a role
CC       during mitosis: recruited to kinetochores by PLK1 during early mitosis
CC       and regulates the maturation of the outer kinetochores and microtubule
CC       attachment. Has no protein kinase activity in vitro (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with KIF23 and RBM44. Interacts with CEP55;
CC       inhibiting interaction between CEP55 and PDCD6IP/ALIX and TSG101 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8IWB6; Q53EZ4: CEP55; NbExp=3; IntAct=EBI-6674697, EBI-747776;
CC       Q8IWB6; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-6674697, EBI-742054;
CC       Q8IWB6; Q9UBR4-2: LHX3; NbExp=5; IntAct=EBI-6674697, EBI-12039345;
CC       Q8IWB6; P61968: LMO4; NbExp=3; IntAct=EBI-6674697, EBI-2798728;
CC       Q8IWB6; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-6674697, EBI-16439278;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Midbody {ECO:0000250}.
CC       Chromosome, centromere, kinetochore {ECO:0000250}. Note=Detected in the
CC       intercellular bridges that connect male germ cell daughter cells after
CC       cell division. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IWB6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWB6-2; Sequence=VSP_019868;
CC       Name=3;
CC         IsoId=Q8IWB6-3; Sequence=VSP_019868, VSP_019869;
CC   -!- TISSUE SPECIFICITY: Expression restricted to testis.
CC       {ECO:0000269|PubMed:11279525, ECO:0000269|PubMed:28206990}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- DOMAIN: The GPPX3Y motif mediates interaction with CEP55.
CC   -!- PTM: Phosphorylated on Thr residues by CDK1 during early phases of
CC       mitosis, promoting the interaction with PLK1 and recruitment to
CC       kinetochores. Phosphorylated on Ser-437 by PLK1 during late
CC       prometaphase promotes the rapid depletion from kinetochores and its
CC       subsequent degradation by the APC/C complex.
CC       {ECO:0000269|PubMed:22405274}.
CC   -!- DISEASE: Spermatogenic failure 23 (SPGF23) [MIM:617707]: An infertility
CC       disorder caused by spermatogenesis defects that result in non-
CC       obstructive azoospermia. {ECO:0000269|PubMed:28206990}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. {ECO:0000305}.
CC   -!- CAUTION: Ser-376 is present instead of the conserved Asp which is
CC       expected to be an active site residue. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK31980.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL834143; CAD38856.2; -; mRNA.
DR   EMBL; AC005666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC040526; AAH40526.1; -; mRNA.
DR   EMBL; AF285601; AAK31980.1; ALT_INIT; mRNA.
DR   EMBL; BK000998; DAA01359.1; -; mRNA.
DR   CCDS; CCDS32692.1; -. [Q8IWB6-3]
DR   CCDS; CCDS32693.1; -. [Q8IWB6-2]
DR   CCDS; CCDS56042.1; -. [Q8IWB6-1]
DR   RefSeq; NP_001188386.1; NM_001201457.1. [Q8IWB6-1]
DR   RefSeq; NP_112562.3; NM_031272.4. [Q8IWB6-3]
DR   RefSeq; NP_938207.2; NM_198393.3. [Q8IWB6-2]
DR   PDB; 3WUT; X-ray; 2.30 A; C/F/I/L=792-804.
DR   PDB; 3WUU; X-ray; 2.90 A; C/F/I/L=791-805.
DR   PDBsum; 3WUT; -.
DR   PDBsum; 3WUU; -.
DR   SMR; Q8IWB6; -.
DR   BioGRID; 121089; 3.
DR   ELM; Q8IWB6; -.
DR   IntAct; Q8IWB6; 6.
DR   STRING; 9606.ENSP00000240361; -.
DR   TCDB; 8.A.23.1.18; the basigin (basigin) family.
DR   iPTMnet; Q8IWB6; -.
DR   PhosphoSitePlus; Q8IWB6; -.
DR   BioMuta; TEX14; -.
DR   DMDM; 110816441; -.
DR   jPOST; Q8IWB6; -.
DR   MassIVE; Q8IWB6; -.
DR   PaxDb; Q8IWB6; -.
DR   PeptideAtlas; Q8IWB6; -.
DR   PRIDE; Q8IWB6; -.
DR   ProteomicsDB; 70835; -. [Q8IWB6-1]
DR   ProteomicsDB; 70836; -. [Q8IWB6-2]
DR   ProteomicsDB; 70837; -. [Q8IWB6-3]
DR   Antibodypedia; 31015; 79 antibodies.
DR   DNASU; 56155; -.
DR   Ensembl; ENST00000240361; ENSP00000240361; ENSG00000121101. [Q8IWB6-1]
DR   Ensembl; ENST00000349033; ENSP00000268910; ENSG00000121101. [Q8IWB6-3]
DR   Ensembl; ENST00000389934; ENSP00000374584; ENSG00000121101. [Q8IWB6-2]
DR   GeneID; 56155; -.
DR   KEGG; hsa:56155; -.
DR   UCSC; uc002iwr.3; human. [Q8IWB6-1]
DR   CTD; 56155; -.
DR   DisGeNET; 56155; -.
DR   GeneCards; TEX14; -.
DR   HGNC; HGNC:11737; TEX14.
DR   HPA; ENSG00000121101; Tissue enriched (testis).
DR   MalaCards; TEX14; -.
DR   MIM; 605792; gene.
DR   MIM; 617707; phenotype.
DR   neXtProt; NX_Q8IWB6; -.
DR   OpenTargets; ENSG00000121101; -.
DR   Orphanet; 399805; Male infertility with azoospermia or oligozoospermia due to single gene mutation.
DR   PharmGKB; PA36454; -.
DR   eggNOG; ENOG410IHZA; Eukaryota.
DR   eggNOG; ENOG410XT67; LUCA.
DR   GeneTree; ENSGT00390000015123; -.
DR   HOGENOM; CLU_004733_0_0_1; -.
DR   InParanoid; Q8IWB6; -.
DR   OMA; HEYFYSS; -.
DR   OrthoDB; 92703at2759; -.
DR   PhylomeDB; Q8IWB6; -.
DR   TreeFam; TF328704; -.
DR   ChiTaRS; TEX14; human.
DR   GenomeRNAi; 56155; -.
DR   Pharos; Q8IWB6; Tbio.
DR   PRO; PR:Q8IWB6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q8IWB6; protein.
DR   Bgee; ENSG00000121101; Expressed in testis and 101 other tissues.
DR   ExpressionAtlas; Q8IWB6; baseline and differential.
DR   Genevisible; Q8IWB6; HS.
DR   GO; GO:0005623; C:cell; ISS:UniProtKB.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; ISS:UniProtKB.
DR   GO; GO:0000776; C:kinetochore; ISS:UniProtKB.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0043063; P:intercellular bridge organization; ISS:UniProtKB.
DR   GO; GO:0007140; P:male meiotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0051306; P:mitotic sister chromatid separation; ISS:UniProtKB.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint; ISS:UniProtKB.
DR   GO; GO:0032466; P:negative regulation of cytokinesis; IEA:Ensembl.
DR   GO; GO:0032091; P:negative regulation of protein binding; IEA:Ensembl.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR039339; Tex14.
DR   PANTHER; PTHR23060; PTHR23060; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; ATP-binding; Cell cycle;
KW   Cell division; Centromere; Chromosome; Cytoplasm; Kinetochore; Mitosis;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat.
FT   CHAIN           1..1497
FT                   /note="Inactive serine/threonine-protein kinase TEX14"
FT                   /id="PRO_0000246995"
FT   REPEAT          27..54
FT                   /note="ANK 1"
FT   REPEAT          55..84
FT                   /note="ANK 2"
FT   REPEAT          88..117
FT                   /note="ANK 3"
FT   DOMAIN          227..518
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         233..241
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOTIF           795..801
FT                   /note="GPPX3Y"
FT   MOTIF           852..860
FT                   /note="D-box"
FT   BINDING         273
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         175
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:F1M5M3"
FT   MOD_RES         437
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7M6U3"
FT   MOD_RES         567
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:F1M5M3"
FT   MOD_RES         665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:F1M5M3"
FT   MOD_RES         1106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7M6U3"
FT   MOD_RES         1404
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7M6U3"
FT   MOD_RES         1459
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7M6U3"
FT   MOD_RES         1496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7M6U3"
FT   VAR_SEQ         213..218
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11279525,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_019868"
FT   VAR_SEQ         1064..1103
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11279525,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_019869"
FT   VARIANT         88
FT                   /note="D -> G (in dbSNP:rs56292204)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041388"
FT   VARIANT         321
FT                   /note="K -> E (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041389"
FT   VARIANT         443
FT                   /note="S -> C"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041390"
FT   VARIANT         559
FT                   /note="I -> M"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041391"
FT   MUTAGEN         614..618
FT                   /note="SSPST->AAPAA: In PBD-1; reduced ability to interact
FT                   with PLK1"
FT                   /evidence="ECO:0000269|PubMed:22405274"
FT   MUTAGEN         726..728
FT                   /note="STT->AAA: In PBD-5; reduced ability to interact with
FT                   PLK1"
FT                   /evidence="ECO:0000269|PubMed:22405274"
FT   CONFLICT        1326
FT                   /note="H -> R (in Ref. 4; AAK31980)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1387
FT                   /note="L -> P (in Ref. 1; CAD38856)"
FT                   /evidence="ECO:0000305"
FT   STRAND          797..800
FT                   /evidence="ECO:0000244|PDB:3WUT"
SQ   SEQUENCE   1497 AA;  167901 MW;  D7DC446A1A18FC4D CRC64;
     MSRAVRLPVP CPVQLGTLRN DSLEAQLHEY VKQGNYVKVK KILKKGIYVD AVNSLGQTAL
     FVAALLGLRK FVDVLVDYGS DPNHRCFDGS TPVHAAAFSG NQWILSKLLD AGGDLRLHDE
     RGQNPKTWAL TAGKERSTQI VEFMQRCASH MQAIIQGFSY DLLKKIDSPQ RLVYSPSWCG
     GLVQGNPNGS PNRLLKAGVI SAQNIYSFGF GKAMPWFQFY LTGATQMAYL GSLPVIGEKE
     VIQADDEPTF SFFSGPYMVM TNLVWNGSRV TVKELNLPTH PHCSRLRLAD LLIAEQEHSS
     KLRHPYLLQL MAVCLSQDLE KTRLVYERIT IGTLFSVLHE RRSQFPVLHM EVIVHLLLQI
     SDALRYLHFQ GFIHRSLSSY AVHIISPGEA RLTNLEYMLE SEDRGVQRDL TRVPLPTQLY
     NWAAPEVILQ KAATVKSDIY SFSMIMQEIL TDDIPWKGLD GSVVKKAVVS GNYLEADVRL
     PKPYYDIVKS GIHVKQKDRT MNLQDIRYIL KNDLKDFTGA QRTQPTESPR VQRYGLHPDV
     NVYLGLTSEH PRETPDMEII ELKEMGSQPH SPRVHSLFTE GTLDPQAPDP CLMARETQNQ
     DAPCPAPFMA EEASSPSTGQ PSLCSFEINE IYSGCLILED DIEEPPGAAS SLEADGPNQV
     DELKSMEEEL DKMEREACCF GSEDESSSKA ETEYSFDDWD WQNGSLSSLS LPESTREAKS
     NLNNMSTTEE YLISKCVLDL KIMQTIMHEN DDRLRNIEQI LDEVEMKQKE QEERMSLWAT
     SREFTNAYKL PLAVGPPSLN YIPPVLQLSG GQKPDTSGNY PTLPRFPRML PTLCDPGKQN
     TDEQFQCTQG AKDSLETSRI QNTSSQGRPR ESTAQAKATQ FNSALFTLSS HRQGPSASPS
     CHWDSTRMSV EPVSSEIYNA ESRNKDDGKV HLKWKMEVKE MAKKAATGQL TVPPWHPQSS
     LTLESEAENE PDALLQPPIR SPENTDWQRV IEYHRENDEP RGNGKFDKTG NNDCDSDQHG
     RQPRLGSFTS IRHPSPRQKE QPEHSEAFQA SSDTLVAVEK SYSHQSMQST CSPESSEDIT
     DEFLTPDGEY FYSSTAQENL ALETSSPIEE DFEGIQGAFA QPQVSGEEKF QMRKILGKNA
     EILPRSQFQP VRSTEDEQEE TSKESPKELK EKDISLTDIQ DLSSISYEPD SSFKEASCKT
     PKINHAPTSV STPLSPGSVS SAASQYKDCL ESITFQVKTE FASCWNSQEF IQTLSDDFIS
     VRERAKKLDS LLTSSETPPS RLTGLKRLSS FIGAGSPSLV KACDSSPPHA TQRRSLPKVE
     AFSQHHIDEL PPPSQELLDD IELLKQQQGS STVLHENTAS DGGGTANDQR HLEEQETDSK
     KEDSSMLLSK ETEDLGEDTE RAHSTLDEDL ERWLQPPEES VELQDLPKGS ERETNIKDQK
     VGEEKRKRED SITPERRKSE GVLGTSEEDE LKSCFWKRLG WSESSRIIVL DQSDLSD
//
